BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 2202125)

  • 21. Corticosteroid withdrawal with substitution of azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Florence-Green D; Norris C; Oh HK; Dienst S; Levin NW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2024-6. PubMed ID: 3274465
    [No Abstract]   [Full Text] [Related]  

  • 22. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
    MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
    [No Abstract]   [Full Text] [Related]  

  • 23. Discontinuation of one drug in triple drug treatment of renal allograft patients: 1-year results.
    Isoniemi H; Eklund B; Höckerstedt K; Korsbäck C; Salmela K; von Willebrand E; Häyry P; Ahonen J
    Transplant Proc; 1990 Aug; 22(4):1365-6. PubMed ID: 2202111
    [No Abstract]   [Full Text] [Related]  

  • 24. Subpopulations of peripheral blood mononuclear cells are reliable for monitoring infiltrating mononuclear cells.
    Takahara S; Sakakibara I; Suzuki S; Amemiya H; Kokado Y; Ishibashi M; Sonoda T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1846-51. PubMed ID: 2652601
    [No Abstract]   [Full Text] [Related]  

  • 25. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
    Reissi D; Bardideh A; Samadzadeh B; Razi A
    Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
    Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
    [No Abstract]   [Full Text] [Related]  

  • 27. Mizoribine in combination therapy with tacrolimus for living donor renal transplantation: analysis of a nationwide study in Japan.
    Akiyama T; Okazaki H; Takahashi K; Hasegawa A; Tanabe K; Uchida K; Takahara S; Toma H
    Transplant Proc; 2005 Mar; 37(2):843-5. PubMed ID: 15848551
    [No Abstract]   [Full Text] [Related]  

  • 28. Triple drug therapy in haploidentical living related and cadaveric kidney transplantation.
    Diliz-Pérez H; Alvarez L; Zúñiga V; Estefan J; Mares J; Cerda L; Luque E; Carrera B; Volkow P; Martínez R
    Transplant Proc; 1991 Apr; 23(2):1747-8. PubMed ID: 2053142
    [No Abstract]   [Full Text] [Related]  

  • 29. Early fluctuation in cyclosporine A trough levels affects long-term outcome of kidney transplants.
    Inoue S; Beck Y; Nagao T; Uchida H
    Transplant Proc; 1994 Oct; 26(5):2571-3. PubMed ID: 7940795
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunosuppression with low-dose cyclosporine combined with bredinin and prednisolone.
    Aso K; Uchida H; Sato K; Yokota K; Osakabe T; Nakayama Y; Ohkubo M; Kumano K; Endo T; Koshiba K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1955-8. PubMed ID: 3547900
    [No Abstract]   [Full Text] [Related]  

  • 31. A controlled trial of triple therapy in renal transplantation.
    Salaman JR; Griffin PJ; Ross WB; Williams JD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1935-6. PubMed ID: 3079061
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasma endothelin level following kidney transplantation.
    Kumano K; Masui N; Soh S; Mashimo S; Endo T
    Transplant Proc; 1994 Aug; 26(4):2114-6. PubMed ID: 8066688
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclosporine in cadaveric renal transplantation: a comparison of two immunosuppressive protocols.
    Koyle M; Glassock R; Rajfer J; Ward H
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1849. PubMed ID: 3079048
    [No Abstract]   [Full Text] [Related]  

  • 34. Low-dose cyclosporine or azathioprine one year after renal transplantation.
    Forwell MA; Bradley JA; Briggs JD; Brown MW; Junor BJ; Macpherson SG; Watson MA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1858-9. PubMed ID: 3079052
    [No Abstract]   [Full Text] [Related]  

  • 35. A prospective study on the influence of cyclosporine and azathioprine on renal allograft survival and function.
    Henny FC; Kootte AM; van Bockel JH; Baldwin WM; Hermans J; Bos B; van Es LA; Paul LC
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1853-5. PubMed ID: 3079050
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of deoxyspergualin on acute and chronic rejection in renal transplantation.
    Nomura Y; Tomikawa S; Beck Y; Nishimura Y; Meigata K; Ando Y; Kikuchi K
    Transplant Proc; 1998 Nov; 30(7):3580-1. PubMed ID: 9838568
    [No Abstract]   [Full Text] [Related]  

  • 37. Elective conversion from cyclosporine to azathioprine and prednisolone in patients after cadaveric renal transplantation: observations on graft survival and renal function.
    Tegzess AM; van Son WJ; de Maar EF; Beelen JM; Sluiter WJ; Huisman RM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1635-7. PubMed ID: 2652534
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term outcome of cadaveric kidney grafts with triple drug therapy.
    Amemiya H; Suzuki S; Hayashi R; Nakatani T
    Transplant Proc; 1994 Aug; 26(4):2097-8. PubMed ID: 8066683
    [No Abstract]   [Full Text] [Related]  

  • 39. Monotherapy with cyclosporine in kidney transplantation.
    Andreu J; Campistol JM; Oppenheimer F; Ricart MJ; Vilardell J; Carretero P
    Transplant Proc; 1990 Oct; 22(5):2270-1. PubMed ID: 2219364
    [No Abstract]   [Full Text] [Related]  

  • 40. Living-related kidney transplantation using low-dose triple immunosuppression.
    Rashid HU; Rahman M; Wahab MA; Kibria G; Rahman S; Jinnat S
    Transplant Proc; 1994 Aug; 26(4):2089. PubMed ID: 8066680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.